Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for UCB-Pharma
Company Monitoring Page for UCB-Pharma
latest headlines for company on cafepharma
UCB's orchestra hits dud note: Novartis-partnered Parkinson's asset fails phase 2
Fierce Biotech
Tue, 12/17/24 - 11:58 am
Tags:
UCB Pharma
,
Novartis
,
Parkinson's Disease
,
minzasolmin
,
clinical trials
GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more
Fierce Pharma
Sun, 11/10/24 - 09:33 pm
Tags:
GSK
,
BIO
,
Pfizer
,
Takeda
,
UCB Pharma
UCB's tau drug flunks phase 2 Alzheimer's trial days after Roche's exit from $120M bet
Fierce Biotech
Fri, 11/1/24 - 10:55 am
Tags:
UCB Pharma
,
clinical trials
,
Roche
,
Alzheimer's disease
,
bepranemab
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Fierce Biotech
Tue, 10/22/24 - 11:25 am
Tags:
Roche
,
UCB Pharma
,
anti-tau antibodies
,
bepranemab
,
Alzheimer's disease
UCB, Biogen lupus drug scores in phase 3 trial
Pharmaphorum
Tue, 09/24/24 - 11:37 am
Tags:
UCB Pharma
,
Biogen
,
systemic lupus erythematosus
,
clinical trials
,
dapirolizumab pegol
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Fierce Pharma
Mon, 09/23/24 - 10:19 pm
Tags:
UCB Pharma
,
Bimzelx
,
FDA
,
psoriatic arthritis
,
radiographic axial spondyloarthritis
,
ankylosing spondylitis
UCB sells off production plant and a clutch of older meds in China for $680M
Fierce Pharma
Mon, 08/26/24 - 11:09 am
Tags:
UCB Pharma
,
China
UCB leads pharma in CX, according to DT Consulting survey
Medical Marketing and Media
Mon, 08/12/24 - 05:56 pm
Tags:
UCB Pharma
,
Customer Experience
,
physicians
,
HCPs
Takeda ditches industry trade group BIO following exits by WuXi AppTec, Pfizer and UCB
Fierce Pharma
Fri, 04/26/24 - 11:44 am
Tags:
Pfizer
,
UCB Pharma
,
WuXi AppTec
,
Takeda
,
BIO
UCB launches DTC Bimzelx ad blitz at the Oscars
Medical Marketing and Media
Sun, 03/10/24 - 08:23 pm
Tags:
UCB Pharma
,
DTC advertising
,
Oscars
,
psoriasis
Seeking blockbuster status, UCB eyes 4 new indications for psoriasis med Bimzelx in 2024
Fierce Pharma
Wed, 02/28/24 - 09:47 pm
Tags:
UCB Pharma
,
Bimzelx
After Pfizer's exit, UCB splits from industry trade group BIO
Fierce Pharma
Sun, 01/7/24 - 04:20 pm
Tags:
UCB Pharma
,
BIO
,
Pfizer
Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines
BioSpace
Mon, 11/13/23 - 11:58 am
Tags:
ViaNautis Bio
,
Eli Lilly
,
genetic nanomedicine
,
UCB Pharma
,
funding
FDA Approves UCB’s Complement Inhibitor for Generalized Myasthenia Gravis
BioSpace
Wed, 10/18/23 - 11:22 am
Tags:
UCB Pharma
,
Zilbrysq
,
myasthenia gravis
UCB stakes claim to gMG market as FDA clears Rystiggo
Pharmaphorum
Tue, 06/27/23 - 11:21 am
Tags:
UCB Pharma
,
Rystiggo
,
myasthenia gravis
,
FDA
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
UCB partners with Ariceum for treatment of immune-related diseases and cancer
Biopharma Reporter
Fri, 05/12/23 - 11:30 am
Tags:
UCB Pharma
,
Ariceum
,
R&D
,
radiopharmaceuticals
,
solid tumors
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Tue, 04/11/23 - 10:04 am
Tags:
Novartis
,
Cosentyx
,
AbbVie
,
Humira
,
hidradenitis suppurativa
,
UCB Pharma
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
Tue, 04/4/23 - 10:10 am
Tags:
AbbVie
,
Humira
,
hidradenitis suppurativa
,
UCB Pharma
,
Bimzelx
,
MoonLake Immunotherapeutics
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
Tue, 03/21/23 - 09:54 am
Tags:
AAD
,
hidradenitis suppurativa
,
AbbVie
,
Humira
,
UCB Pharma
,
Bimzelx
,
Acelyrin
,
izokibep
Pages
1
2
3
4
5
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.